Global Budget Revenue Model and Care for Patients Receiving Chemotherapy
This cohort study of patients with systemic anticancer therapy episodes showed that Maryland's GBR model was associated with substantial reductions in the growth of Medicare payments. These savings may have been achieved by shifting care toward lower-cost treatment settings.
Authors
- Bradley Herring (ORCID: https://orcid.org/0000-0001-6845-1412)
- Laura A. Petrillo (ORCID: https://orcid.org/0000-0002-8721-4858)
- Yu Lin
- Alexander Melamed
- Anaeze C. Offodile
- Nancy L. Keating
Institutions
- Brigham and Women's Hospital (US)
- Memorial Sloan Kettering Cancer Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- Harvard University (US)
- University of New Hampshire (US)
- Massachusetts General Hospital (US)
- Department of Health Services (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2026-03-05
- DOI
- https://doi.org/10.1001/jamanetworkopen.2026.0485
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Justice
- Memorial Sloan-Kettering Cancer Center
- National Institutes of Health
- Weill Cornell Medical College
- National Cancer Institute